Stevanato Group S.p.A. Stock Prediction
AI-powered sentiment analysis and prediction trends for STVN, updated each market day.
STVN AI Sentiment
AI sees no strong directional signal for Stevanato Group S.p.A. stock over the next 10 market days.
Prediction date: Aug. 28, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Stevanato Group S.p.A.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.
Exchange
Market Cap
$6,090,713,747
Cap Tier
Employees
5,795
Listed Since
July 16, 2021
Website
STVN Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
STVN Volatility
Stevanato Group S.p.A. has shown moderate price volatility over the last 5 trading days. Moderate volatility indicates normal market activity with typical price fluctuations.
